Form D · Biotechnology
S4 Medical Corp.
Cleveland, OH · CIK 0001727260
Offering snapshot reported Jul 20, 2020 · SEC filing
- Reported sold
- $1.86M Offering amount: $2.2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 20, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 20, 2020 | Initial | $1,855,000 | No comparison | 8 | SEC filing |
| Jan 5, 2018 | Initial | $600,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-371400
Source: Form D, filed Jul 20, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Emile Daoud | Director, Executive |
| William Fuller | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11000 Cedar Avenue
Cleveland, OH, 44106
Cleveland, OH, 44106